(Q42921046)

11 November 2017

title

Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments (English)

1 reference

11 November 2017

1 reference

14

1 reference

11 November 2017

13

Alison M Strack

1 reference

11 November 2017

11

Ravi P Nargund

1 reference

11 November 2017

Joseph M Metzger

1

1 reference

11 November 2017

Karen Gagen

2

1 reference

11 November 2017

Kate A Raustad

3

1 reference

11 November 2017

Liming Yang

4

1 reference

11 November 2017

Amanda White

5

1 reference

11 November 2017

Sheng-Ping Wang

6

1 reference

11 November 2017

Stephanie Craw

7

1 reference

11 November 2017

Ping Liu

8

1 reference

11 November 2017

Thomas Lanza

9

1 reference

11 November 2017

Linus S Lin

10

1 reference

11 November 2017

Xiao-Ming Guan

12

1 reference

11 November 2017

language of work or name

1 reference

31 August 2010

1 reference

American Journal of Physiology - Endocrinology and Metabolism

11 November 2017

published in

1 reference

11 November 2017

volume

299

1 reference

11 November 2017

issue

5

1 reference

11 November 2017

page(s)

E816-24

1 reference

betaAR signaling required for diet-induced thermogenesis and obesity resistance

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Brown adipose tissue: function and physiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Torpor in mice is induced by both leptin-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Metabolic rate and body temperature reduction during hibernation and daily torpor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Locomotion is the major determinant of sibutramine-induced increase in energy expenditure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Synthesis and SAR of potent and orally bioavailable tert-butylpyrrolidine archetype derived melanocortin subtype-4 receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Central control of fever and female body temperature by RANKL/RANK

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Food restriction increases torpor and improves brown adipose tissue thermogenesis in ob/ob mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Calorie restriction mimetics: an emerging research field

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Mechanism of the anti-obesity effects induced by a novel melanin-concentrating hormone 1-receptor antagonist in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Hyperphagia, lower body temperature, and reduced running wheel activity precede development of morbid obesity in New Zealand obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Factors contributing to obesity in bombesin receptor subtype-3-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Calorie restriction lowers body temperature in rhesus monkeys, consistent with a postulated anti-aging mechanism in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Transduction of receptor signals by beta-arrestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Molecular basis of the pharmacological difference between rat and human bombesin receptor subtype-3 (BRS-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

The discovery and status of sibutramine as an anti-obesity drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Torpor induction in mammals: recent discoveries fueling new ideas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Central control of thermogenesis in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Cloning and expression of the neuromedin B receptor and the third subtype of bombesin receptor genes in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Selectivity of cyclic [D-Nal7] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Roles of the melanocortin-4 receptor in antipyretic and hyperthermic actions of centrally administered alpha-MSH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Targeted disruption of the beta 3-adrenergic receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

CB1 cannabinoid receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

Hyperresponsiveness to palatable and aversive taste stimuli in genetically obese (bombesin receptor subtype-3-deficient) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00404.2010

10.1152/AJPENDO.00404.2010

21 January 2018

Identifiers

DOI

1 reference

11 November 2017

1 reference